Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HERAX | 10.44 | -0.01 | -0.10% |
| Hartford Emerging Markets Equity A | |||
| RMFGX | 57.91 | -0.62 | -1.06% |
| American Funds American Mutual R6 | |||
| LZUSX | 16.83 | -0.29 | -1.69% |
| Lazard US Equity Focus Instl | |||
| GCTCX | 43.19 | -0.93 | -2.11% |
| Goldman Sachs US Tax-Managed Eq C | |||
| PBQAX | 24.27 | -0.56 | -2.26% |
| PGIM Jennison Blend A | |||
A.I.dvisor tells us that SRBCF and BCLI have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SRBCF and BCLI's prices will move in lockstep.
| Ticker / NAME | Correlation To SRBCF | 1D Price Change % | ||
|---|---|---|---|---|
| SRBCF | 100% | N/A | ||
| BCLI - SRBCF | 25% Poorly correlated | -3.89% | ||
| PRTG - SRBCF | 21% Poorly correlated | -2.56% | ||
| TRRI - SRBCF | 12% Poorly correlated | N/A | ||
| VBIZF - SRBCF | 12% Poorly correlated | N/A | ||
| SBMFF - SRBCF | 8% Poorly correlated | N/A | ||
More | ||||